ID: ALA609141

Max Phase: Preclinical

Molecular Formula: C12H21NO

Molecular Weight: 195.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(=O)/C(C)=C/C1CCCCN1C

Standard InChI:  InChI=1S/C12H21NO/c1-4-12(14)10(2)9-11-7-5-6-8-13(11)3/h9,11H,4-8H2,1-3H3/b10-9+

Standard InChI Key:  GTWYJRCFEOWTHB-MDZDMXLPSA-N

Associated Targets(non-human)

Neuronal acetylcholine receptor 756 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 195.31Molecular Weight (Monoisotopic): 195.1623AlogP: 2.40#Rotatable Bonds: 3
Polar Surface Area: 20.31Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.21CX LogP: 2.68CX LogD: 1.81
Aromatic Rings: 0Heavy Atoms: 14QED Weighted: 0.64Np Likeness Score: 0.64

References

1. Villeneuve G, Cécyre D, Lejeune H, Drouin M, Lan R, Quirion R..  (2003)  Rigidified acetylcholine mimics: conformational requirements for binding to neuronal nicotinic receptors.,  13  (21): [PMID:14552793] [10.1016/s0960-894x(03)00728-5]

Source